| Ident. | Authors (with country if any) | Title |
|---|
| 000055 (2017) |
Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil] | Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype. |
| 000256 (2016) |
Fang Ba [Canada] ; Mona Obaid [Canada] ; Marguerite Wieler [Canada] ; Richard Camicioli [Canada] ; W R Wayne Martin [Canada] | Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype. |
| 000B02 (2014) |
Chelsea Lowther [Canada] ; Gregory Costain [Canada] ; Dimitri J. Stavropoulos [Canada] ; Rebecca Melvin [Canada] ; Candice K. Silversides [Canada] ; Danielle M. Andrade [Canada] ; Joyce So [Canada] ; Hanna Faghfoury [Canada] ; Anath C. Lionel [Canada] ; Christian R. Marshall [Canada] ; Stephen W. Scherer [Canada] ; Anne S. Bassett [Canada] | Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature |
| 000C21 (2013) |
David N. Cooper ; Michael Krawczak [Allemagne] ; Constantin Polychronakos [Canada] ; Chris Tyler-Smith ; Hildegard Kehrer-Sawatzki [Allemagne] | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
| 000D14 (2013) |
Flavia S. Lakschevitz [Canada] ; Guy M. Aboodi [Canada] ; Michael Glogauer [Canada] | Oral Neutrophil Transcriptome Changes Result in a Pro-Survival Phenotype in Periodontal Diseases |
| 000E70 (2013) |
Sangeena Salam ; Ata Ansari ; Siavash Amon ; Pouya Rezai ; P. Ravi Selvaganapathy ; Ram K. Mishra ; Bhagwati P. Gupta | A microfluidic phenotype analysis system reveals function of sensory and dopaminergic neuron signaling in C. elegans electrotactic swimming behavior |
| 001334 (2012) |
Me Ketelaar [Canada, Pays-Bas] ; Rmw Hofstra [Pays-Bas] ; Mr Hayden [Canada] | What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration |
| 001376 (2012) |
Kaitlyn P. Roland ; Jennifer M. Jakobi ; Colin Powell [Canada] ; Gareth R. Jones | Quality of Life As a Determinant of Frailty Phenotype in Community‐Dwelling Persons with Parkinson's Disease |
| 001391 (2012) |
Tomasz Adamusiak [Royaume-Uni] ; Helen Parkinson [Royaume-Uni] ; Juha Muilu [Finlande] ; Erik Roos [Pays-Bas] ; Kasper Joeri Van Der Velde [Pays-Bas] ; Gudmundur A. Thorisson [Royaume-Uni] ; Myles Byrne [Finlande] ; Chao Pang [Pays-Bas] ; Sirisha Gollapudi [Royaume-Uni] ; Vincent Ferretti [Canada] ; Hans Hillege [Pays-Bas] ; Anthony J. Brookes [Royaume-Uni] ; Morris A. Swertz [Royaume-Uni, Finlande, Pays-Bas] | Observ‐OM and Observ‐TAB: Universal syntax solutions for the integration, search, and exchange of phenotype and genotype information |
| 001702 (2011) |
Nicole Philip ; Anne Bassett | Cognitive, Behavioural and Psychiatric Phenotype in 22q11.2 Deletion Syndrome |
| 001818 (2011) |
Kf Schilter [États-Unis] ; A. Schneider [États-Unis] ; T. Bardakjian [États-Unis] ; J-F Soucy [Canada] ; Rc Tyler [États-Unis] ; Lm Reis [États-Unis] ; Ev Semina [États-Unis] | OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype |
| 001877 (2011) |
Judith E. Allanson [Canada] ; Göran Annerén ; Yoki Aoki ; Christine M. Armour ; Marie-Louise Bondeson ; Helene Cave ; Karen W. Gripp ; Bronwyn Kerr ; Anna-Maja Nystrom ; Katia Sol-Church ; Alain Verloes ; Martin Zenker | Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype? |
| 001925 (2011) |
C. Marras [Canada] ; B. Schuele [États-Unis] ; R. P. Munhoz [Brésil] ; E. Rogaeva [Canada] ; J. W. Langston [États-Unis] ; M. Kasten [Allemagne] ; C. Meaney [Canada] ; C. Klein [Allemagne] ; P. M. Wadia [Canada] ; S.-Y. Lim [Canada] ; R. S.-I. Chuang [Canada] ; C. Zadikof [Canada] ; T. Steeves [Canada] ; K. M. Prakash [Canada] ; R. M. A. De Bie [Canada] ; G. Adeli [Canada] ; T. Thomsen [Canada] ; K. K. Johansen [Norvège] ; H. A. Teive [Brésil] ; A. Asante [Canada] ; W. Reginold [Canada] ; A. E. Lang [Canada] | Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers |
| 001A23 (2010) |
Christian Wider [États-Unis] ; Dennis W. Dickson ; Zbigniew K. Wszolek | Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. |
| 001C95 (2010) |
Connie Marras [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] ; Yosuke Wakutani [Canada] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Edwin Yip [Canada] ; Renato P. Munhoz [Brésil] ; Katja Lohmann [Allemagne] ; Ana Dj Armati [Allemagne] ; Andrew Bi [Canada] ; Ekaterina Rogaeva [Canada] | LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation |
| 002155 (2008) |
Daniel G. Healy [Royaume-Uni] ; Mario Falchi [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Vincenzo Bonifati [Pays-Bas] ; Alexandra Durr [France] ; Susan Bressman [États-Unis] ; Alexis Brice [France] ; Jan Aasly [Norvège] ; Cyrus P. Zabetian [États-Unis] ; Stefano Goldwurm [Italie] ; Joaquim J. Ferreira [Portugal] ; Eduardo Tolosa [Espagne] ; Denise M. Kay [États-Unis] ; Christine Klein [Allemagne] ; David R. Williams [Australie] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Jose Berciano [Espagne] ; Anthony Hv Schapira [Royaume-Uni] ; Timothy Lynch [Irlande (pays)] ; Kailash P. Bhatia [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Andrew J. Lees [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study |
| 002263 (2008) |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins |
| 002B54 (2004) |
Suneil K. Kalia [Canada] ; Joanne E. Nash ; Andres M. Lozano | To serve and protect? Interventions in the subthalamic nucleus for Parkinson's disease. Commentary on "Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease". |
| 003504 (2000) |
C. F. Lippa [États-Unis] ; J. M. Swearer [États-Unis] ; K. J. Kane [États-Unis] ; D. Nochlin [États-Unis] ; T. D. Bird [États-Unis] ; B. Ghetti [États-Unis] ; L. E. Nee [États-Unis] ; P. St. George-Hyslop [Canada] ; D. A. Pollen [États-Unis] ; D. A. Drachman [États-Unis] | Familial Alzheimer's disease: Site of mutation influences clinical phenotype |
| 003616 (1999) |
Z S Nasreddine [Canada] ; M. Loginov ; L N Clark ; J. Lamarche ; B L Miller ; A. Lamontagne ; V. Zhukareva ; V M Lee ; K C Wilhelmsen ; D H Geschwind | From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. |
| 003C00 (1997) |
Linsen Hu ; Sylvain L. Côté ; A. Claudio Cuello | Differential Modulation of the Cholinergic Phenotype of the Nucleus Basalis Magnocellularis Neurons by Applying NGF at the Cell Body or Cortical Terminal Fields |
